Haoxiang Wei

Haoxiang Wei

Auto-generated profile, based on publicly available information

Haoxiang Wei

Fujian University of Technology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2023 in Advanced Science
Verified
Journal Article
Open access
YHYang Han
Yang Han
HWHaoxiang Wei
Haoxiang Wei
YDYanjun Du
Yanjun Du
ZLZhigang Li
Zhigang Li
SFShien Ping Feng
Shien Ping Feng
DXDongyan Xu
Dongyan Xu
Ionic circuits using ions as charge carriers have demonstrated great potential for flexible and bioinspired electronics. The emerging ionic thermoelectric (iTE) materials can generate a potential difference by virtue of selective thermal diffusion of ions, which provide a new route for thermal sensing with the merits of high flexibility, low cost, and high thermopower. Here, ultrasensitive flexible thermal sensor arrays based on an iTE hydrogel consisting of polyquaternium‐10 (PQ‐10), a cellulose derivative, as the polymer matrix and sodium hydroxide (NaOH) as the ion source are reported. The developed PQ‐10/NaOH iTE hydrogel achieves a thermopower of 24.17 mV K−1, which is among the highest values reported for biopolymer‐based iTE materials. The high p‐type thermopower can be attributed to thermodiffusion of Na+ ions under a temperature gradient, while the movement of OH− ions is impeded by the strong electrostatic interaction with the positively charged quaternary amine groups of PQ‐10. Flexible thermal sensor arrays are developed through patterning the PQ‐10/NaOH iTE hydrogel on flexible printed circuit boards, which can perceive spatial thermal signals with high sensitivity. A smart glove integrated with multiple thermal sensor arrays is further demonstrated, which endows a prosthetic hand with thermal sensation for human–machine interaction.

21 November 2022 in Nano Energy
Verified
Journal Article
Closed access
JZJian Zhang
Jian Zhang
WZWenhua Zhang
Wenhua Zhang
HWHaoxiang Wei
Haoxiang Wei
JTJiaqi Tang
Jiaqi Tang
DLDeyu Li
Deyu Li
DXDongyan Xu
Dongyan Xu

21 June 2024 in International Journal of Thermal Sciences
Verified
Journal Article
Closed access
JTJiaqi Tang
Jiaqi Tang
ZYZhe Yan
Zhe Yan
XWXiaotong Wang
Xiaotong Wang
YLYi Liu
Yi Liu
HWHaoxiang Wei
Haoxiang Wei
DXDongyan Xu
Dongyan Xu

2 September 2022 in Nano Letters
Verified
Journal Article
Closed access
FYFengju Yao
Fengju Yao
SXShunji Xia
Shunji Xia
HWHaoxiang Wei
Haoxiang Wei
JZJiongzhi Zheng
Jiongzhi Zheng
ZYZiyuan Yuan
Ziyuan Yuan
DXDongyan Xu
Dongyan Xu

3 May 2022 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
SMShu Miao
Shu Miao
ZJZe Jiang
Ze Jiang
JLJin Luo
Jin Luo
FZFangxun Zhong
Fangxun Zhong
HWHaoxiang Wei
Haoxiang Wei
YLYunhui Liu
Yunhui Liu
Embryo vitrification is a fundamental technology utilized in assisted reproduction and fertility preservation. Vitrification involves sequential loading and unloading of cryoprotectants (CPAs) with strict time control, and transferring the embryo in a minimum CPA droplet to the vitrification straw. However, manual operation still cannot effectively avoid embryo loss, and the existing automatic vitrification systems have insufficient system reliability, and operate differently from clinical vitrification protocol. Through collaboration with in vitro fertilization (IVF) clinics, we are in the process realizing a robotic system that can automatically conduct the embryo vitrification process, including the pretreatment with CPAs, transfer of embryo to the vitrification straw, and cryopreservation with liquid nitrogen ( $\rm LN_{2}$ ). An open microfluidic chip (OMC) was designed to accommodate the embryo during the automatic CPAs pretreatment process. The design of two chambers connected by a capillary gap facilitated solution exchange around the embryo, and simultaneously reduced the risk of embryo loss in the flow field. In accordance to the well-accepted procedure and medical devices in manual operation, we designed the entire vitrification protocol, as well as the robotic prototype. In a practical experiment using mouse embryos, our robotic system showed a 100 $\%$ success rate in transferring and vitrifying the embryos, achieved comparable embryo survival rates (90.9 $\%$ versus 94.4 $\%$ ) and development rates (90.0 $\%$ versus 94.1 $\%$ ), when compared with the manual group conducted by the senior embryologist. With this study, we aim to facilitate the standardization of clinical vitrification from manual operation to a more efficient and reliable automated process.

19 September 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
SMShu Miao
Shu Miao
CGChenxi Guo
Chenxi Guo
ZJZe Jiang
Ze Jiang
HWHao-Xiang Wei
Hao-Xiang Wei
XJXin Jiang
Xin Jiang
YLYunhui Liu
Yunhui Liu
Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vitrification and is currently the most commonly used method in reproductive centers. However, the Cryotop method requires precise and complex manual manipulation by an embryologist, whose proficiency directly determines the effect of vitrification. Therefore, in this study, an automatic microfluidic system consisting of a novel open microfluidic chip and a set of automatic devices was established as a standardized operating protocol to facilitate the conventional manual Cryotop method and minimize the osmotic shock applied to the oocyte. The proposed open microfluidic system could smoothly change the CPA concentration around the oocyte during vitrification pretreatment, and transferred the treated oocyte to the Cryotop with a tiny droplet. The system better conformed to the operating habits of embryologists, whereas the integration of commercialized Cryotop facilitates the subsequent freezing and thawing processes. With standardized operating procedures, our system provides consistent treatment effects for each operation, leading to comparable survival rate, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) level of oocytes to the manual Cryotop operations. The vitrification platform is the first reported microfluidic system integrating the function of cells transfer from the processing chip, which avoids the risk of cell loss or damage in a manual operation and ensures the sufficient cooling rate during liquid nitrogen (LN2) freezing. Our study demonstrates significant potential of the automatic microfluidic approach to serve as a facile and universal solution for the vitrification of various precious cells.